ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 413.20
+1.20 (0.29%)
Jul 28, 2026, 4:59 PM CET
ChemoMetec Balance Sheet
Financials in millions DKK. Fiscal year is July - June.
Millions DKK. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 274.66 | 341.85 | 296.15 | 316.57 | 209.03 | 150.11 |
Cash & Short-Term Investments | 274.66 | 341.85 | 296.15 | 316.57 | 209.03 | 150.11 |
Cash Growth | -19.65% | 15.43% | -6.45% | 51.45% | 39.25% | 54.85% |
Accounts Receivable | 93 | 79.62 | 62.26 | 54.83 | 65.87 | 50.64 |
Other Receivables | 10.12 | 12.36 | 11.9 | 8.63 | 11.25 | 13.49 |
Total Trade Receivables | 103.12 | 91.98 | 74.16 | 63.46 | 77.12 | 64.14 |
Inventory | 106.66 | 109.34 | 119.5 | 112.64 | 66.79 | 30.11 |
Total Current Assets | 484.44 | 543.16 | 489.8 | 492.66 | 352.93 | 244.36 |
Net Property, Plant & Equipment | 25.99 | 41.35 | 28.17 | 13.54 | 7.71 | 42.5 |
Other Intangible Assets | 160.55 | 145.69 | 94.55 | 79.66 | 67.4 | 57.88 |
Goodwill | 7.36 | 7.35 | - | - | - | - |
Other Long-Term Assets | 11.39 | 16.23 | 0.28 | 2.97 | 6.16 | 0.17 |
Total Assets | 783.37 | 828.05 | 676.67 | 657.98 | 501.27 | 344.91 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 13.68 | 16.08 | 11.09 | 17.55 | 17.02 | 8.71 |
Accrued Expenses | 11.19 | 20.96 | 13.48 | 8.2 | 30.18 | 21.25 |
Short-Term Debt | 1.45 | 1.47 | 1.33 | 1.01 | 1.03 | 0.59 |
Current Portion of Leases | 0.9 | 1.92 | 1.85 | 2.51 | 0.91 | 0.85 |
Unearned Revenue | 60.41 | 54.86 | 50.82 | 46.48 | 33.62 | 18.63 |
Other Current Liabilities | 35.66 | 51.7 | 19.96 | 43.44 | 54.62 | 21.94 |
Total Current Liabilities | 123.28 | 146.99 | 98.53 | 119.19 | 137.38 | 71.97 |
Long-Term Leases | 2.86 | 3.02 | 0.97 | 3.64 | 4.86 | 0.91 |
Other Long-Term Liabilities | 4.65 | 4.68 | 11.85 | 2.1 | 1.83 | 7.05 |
Total Long-Term Liabilities | 7.5 | 7.7 | 12.83 | 5.74 | 6.69 | 7.96 |
Total Liabilities | 130.78 | 154.69 | 111.36 | 124.93 | 144.07 | 79.93 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 |
Accumulated Other Comprehensive Income | 635.19 | 655.95 | 547.91 | 515.64 | 339.8 | 247.58 |
Shareholders' Equity | 652.59 | 673.36 | 565.32 | 533.04 | 357.21 | 264.98 |
Total Liabilities & Equity | 783.37 | 828.05 | 676.67 | 657.98 | 501.27 | 344.91 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 5.21 | 6.4 | 4.16 | 7.16 | 6.79 | 2.36 |
Net Cash (Debt) | 269.45 | 335.45 | 291.99 | 309.41 | 202.23 | 147.75 |
Net Cash Growth | -19.67% | 14.88% | -5.63% | 53.00% | 36.87% | 56.10% |
Net Cash Per Share | 15.48 | 19.28 | 16.78 | 17.78 | 11.62 | 8.49 |
Book Value | 652.59 | 673.36 | 565.32 | 533.04 | 357.21 | 264.98 |
Book Value Per Share | 37.49 | 38.69 | 32.48 | 30.63 | 20.53 | 15.23 |
Tangible Book Value | 484.68 | 520.31 | 470.77 | 453.38 | 289.81 | 207.09 |
Tangible Book Value Per Share | 27.84 | 29.90 | 27.05 | 26.05 | 16.65 | 11.90 |